Projekty uchwał NWZA Scope Fluidics na 07.12.2021

Previous PostOgłoszenie NWZA Scope Fluidics na 07 12 2021Next PostPolityka wynagrodzeń uchwala nr 7 NWZA Scope Fluidics na 07 12 2021

0Shares

Scope Fluidics begins efforts toward certification of the rapid BACTEROMIC panel for Gram-negative bacteria, which could go on sale in 2027

SCOPE FLUIDICS0

15.10.2026

Edocera develops device prototype and confirms its ability to detect signs of stroke

SCOPE FLUIDICS0

30.09.2026

Scope Fluidics after the first half of 2026: strong cash position, IVDR certification and expanding cooperation with distributors

SCOPE FLUIDICS0

CONTACT US

Tel. +48 22 376 21 14
Email: biuro@scopefluidics.com

Address

Ogrodowa 58
9th floor
00-876 Warsaw

KRS: 0000668408

NIP: 527-264-59-89

REGON: 142-754-170

LEI: 259400EUNFX4E2BEHU15

Company registered in the District Court for the Capital City of Warsaw in Warsaw, XII Commercial Division of the National Court Register.

Share capital: PLN 316 827,10 fully paid up

Bank Account Number: 03 2490 0005 0000 4520 3046 2136

Terms of use

Cookies Policy

Information clause

Whistleblower Protection

Projekty uchwał NWZA Scope Fluidics na 07.12.2021

Related Posts

Scope Fluidics begins efforts toward certification of the rapid BACTEROMIC panel for Gram-negative bacteria, which could go on sale in 2027

Edocera develops device prototype and confirms its ability to detect signs of stroke

Scope Fluidics after the first half of 2026: strong cash position, IVDR certification and expanding cooperation with distributors